Neural Therapy in Cesareans

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age19-45
SponsorHaseki Training and Research Hospital

About this trial

In the management of pain after Caesarean section (C/S), opioid or nonsteroidal anti-inflammatory parenteral drugs are applied. These drugs are insufficient in some cases and may cause pain attacks during the day. Higher doses and repeated drug applications or combined drug administration may cause drug side effects and interactions. Alternative applications to provide analgesia include subcutaneous and intracutaneous local anesthetic application to the wound site. Although the effectiveness of these applications has been tested in individuals with different clinical characteristics and has been shown to be largely more successful, they have not been sufficiently introduced into routine practice. There is a need to review the pain methods suggested in the literature and develop new solutions that can be applied more optimally, improve the patient's pain management in the postoperative period, and increase their quality of life and satisfaction.

It aims to evaluate the success of subcutaneous and intracutaneous local anesthesia applications compared to traditional applications, and to find the most optimal management.

Eligibility criteria

Qualifiers

Healthy pregnancy,

Term (>37 weeks) and preterm (28-34 weeks) pregnancy,

Cases that received general anesthesia for cesarean section,

Cases with and without labor,

Disqualifiers

Pregnant women under 19 years of age,

Those with a history of allergic reactions to analgesics to be used,

Stillbirth,

Surgical complications during C/S and placement of an abdominal drain,

Trial design

Treatments tested in this trial

  • neural therapy

Treatment groups

156 Participants
are divided into 3 treatment groups

Locations

This trial has no locations